![](/img/cover-not-exists.png)
Twice‐Daily Triple Nucleoside Intensification Treatment with Lamivudine‐Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET Study
Henry, Keith, Wallace, Robert J., Bellman, Paul C., Norris, Dorece, Fisher, Robin L., Ross, Lisa L., Liao, Qiming, Shaefer, Mark S.Volume:
183
Language:
english
Journal:
The Journal of Infectious Diseases
DOI:
10.1086/318527
Date:
February, 2001
File:
PDF, 111 KB
english, 2001